Illumina News

Aktie
WKN:  927079 ISIN:  US4523271090 US-Symbol:  ILMN Land:  USA
107,08 €
+3,96 €
+3,84%
30.04.26
Depot/Watchlist
Marktkapitalisierung *
18,15 Mrd. €
Streubesitz
-
KGV
28,17
Nachhaltigkeits-Score
66 %
Index-Zuordnung
Nasdaq Composite Index
Weiter aufwärts? Long handeln - Jetzt mit Hebel 5,94: MM6SGD
Werbung

Illumina News

30.04.26 - IT-Times
Illumina Reports Financial Results for First Quarter of Fiscal Year 2026
30.04.26 - PR Newswire
Illumina Reports Financial Results for First Quarter of Fiscal Year 2026
Illumina Reports Financial Results for First Quarter of Fiscal Year 2026 PR Newswire
16.04.26 - IT-Times
DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows
16.04.26 - PR Newswire
DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows
DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows PR Newswire
14.04.26 wallstreetONLINE Redaktion
Hebel-Idee | Long-Chance: Statt BioNTech oder Evotec könnte jetzt diese Biotech-Aktie eine Rallye zünden!
Bei der Aktie von Illumina läuft ein Turnaround auf Mehrjahresebene. Nach einer Konsolidierung besteht für Anleger jetzt wieder die Chance zum Einstieg. Willkommen zum ...
14.04.26 - IT-Times
Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease
14.04.26 - PR Newswire
Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease
Illumina and the Center for Data-​Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease PR Newswire
09.04.26 - IT-Times
Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026
09.04.26 - PR Newswire
Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026
Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026 PR Newswire
02.04.26 - PR Newswire
Illumina Announces Changes to Board of Directors
Illumina Announces Changes to Board of Directors PR Newswire
18.03.26 - PR Newswire
Illumina and Labcorp expand collaboration to broaden access to precision oncology testing
Illumina and Labcorp expand collaboration to broaden access to precision oncology testing PR Newswire
16.03.26 - PR Newswire
Illumina advances preventive genomics through strategic consortium with Veritas Genetics
Illumina advances preventive genomics through strategic consortium with Veritas Genetics PR Newswire
05.03.26 - PR Newswire
Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering
Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering PR Newswire
27.02.26 - PR Newswire
Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida
Illumina whole-​genome sequencing technology to accelerate rare disease testing in Florida PR Newswire
25.02.26 - PR Newswire
Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics
Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics PR Newswire
24.02.26 - PR Newswire
Illumina launches TruPath Genome, setting a new standard in genomic insight
Illumina launches TruPath Genome, setting a new standard in genomic insight PR Newswire
23.02.26 - PR Newswire
Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility
Illumina unveils roadmap of groundbreaking NovaSeq X advancements in data quality, output, speed, and flexibility PR Newswire
17.02.26 - PR Newswire
Illumina To Webcast Upcoming Investor Conference
Illumina To Webcast Upcoming Investor Conference PR Newswire
05.02.26 - PR Newswire
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025 PR Newswire
03.02.26 - PR Newswire
Illumina and the San Diego Zoo Wildlife Alliance partner to sequence the Frozen Zoo®, supporting critical conservation genetics efforts globally
Illumina and the San Diego Zoo Wildlife Alliance partner to sequence the Frozen Zoo®, supporting critical conservation genetics efforts globally PR Newswire

Newssuche

Videos

newspaper
26.04.26
Big Fish Strategy Einführung
Strategie-​Paket inklusive Live-​Webinar am 3.5., Videoaufzeichnung, Unterlagen und Nachbetreuung JETZT ... Mehr »